Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

Martine J. Piccart-Gebhart, Marion Procter, Brian Leyland-Jones, Aron Goldhirsch, Michael Untch, Ian Smith, Luca Gianni, Jose Baselga, Richard Bell, Christian Jackisch, David Cameron, Mitch Dowsett, Carlos H. Barrios, Günther Steger, Chiun Shen Huang, Michael Andersson, Moshe Inbar, Mikhail Lichinitser, István Láng, Ulrike NitzHiroji Iwata, Christoph Thomssen, Caroline Lohrisch, Thomas M. Suter, Josef Rüschoff, Tamás Süto, Victoria Greatorex, Carol Ward, Carolyn Straehle, Eleanor McFadden, M. Stella Dolci, Richard D. Gelber

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences